Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals

被引:81
作者
Biasin, Mara
Piacentini, Luca
Lo Caputo, Sergio
Kanari, Yasuyoshi
Magri, Giuliana
Trabattoni, Daria
Naddeo, Valentina
Lopalco, Lucia
Clivio, Alberto
Cesana, Eugenio
Fasano, Francesca
Bergamaschi, Cristina
Mazzotta, Francesco
Miyazawa, Masaaki
Clerici, Mario
机构
[1] Univ Milan, DISP LITA Vialba, Dept Immunol, I-20157 Milan, Italy
[2] Univ Milan, DISP LITA Vialba, Dept Biol, I-20157 Milan, Italy
[3] SM Annunziata Hosp, Infect Dis Clin, Florence, Italy
[4] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan
[5] Duke Univ, Med Ctr, Dept Surg, Lab AIDS Vaccine Res & Dev, Durham, NC 27710 USA
关键词
D O I
10.1086/511988
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), a human cytidine deaminase, is a potent inhibitor of HIV replication. To explore a possible role of this protein in modulating in vivo susceptibility to HIV infection, we analyzed APOBEC3G expression in HIV-exposed seronegative individuals, HIV-seropositive patients, and healthy control subjects. The results showed that the expression of APOBEC3G is significantly increased in peripheral blood mononuclear cells (PBMCs)-mainly CD14(+) cells-and in cervical tissues of HIV-exposed seronegative individuals. Higher APOBEC3G expression correlated with a reduced susceptibility of PBMCs to in vitro infection with the HIV-1(Ba-L) R5 strain. APOBEC3G could be important in modulating in vivo susceptibility to sexually transmitted HIV infection.
引用
收藏
页码:960 / 964
页数:5
相关论文
共 15 条
  • [1] Selective sequestration of X4 isolates by human genital epithelial cells:: Implication for virus tropism selection process during sexual transmission of HIV
    Berlier, W
    Bourlet, T
    Lawrence, P
    Hamzeh, H
    Lambert, C
    Genin, C
    Verrier, B
    Dieu-Nosjean, MC
    Pozzetto, B
    Delézay, O
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (04) : 465 - 474
  • [2] Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women
    Biasin, M
    Lo Caputo, S
    Speciale, L
    Colombo, F
    Racioppi, L
    Zagliani, A
    Blé, C
    Vichi, F
    Cianferoni, L
    Masci, AM
    Villa, ML
    Ferrante, P
    Mazzotta, F
    Clerici, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) : 1365 - 1374
  • [3] Alpha interferon potently enhances the anti-human immunodeficiency virus type I activity of APOBEC3G in resting primary CD4 T cells
    Chen, Keyang
    Huang, Jialing
    Zhang, Chune
    Huang, Sophia
    Nunnari, Giuseppe
    Wang, Feng-xiang
    Tong, Xiangrong
    Gao, Ling
    Nikisher, Kristi
    Zhang, Hui
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (15) : 7645 - 7657
  • [4] RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
    Chiu, YL
    Soros, VB
    Kreisberg, JF
    Stopak, K
    Yonemoto, W
    Greene, WC
    [J]. NATURE, 2005, 435 (7038) : 108 - 114
  • [5] FRIEDMAN RM, 1988, TXB IMMUNOPHYSIOLOGY, P94
  • [6] Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
    Mangeat, B
    Turelli, P
    Caron, G
    Friedli, M
    Perrin, L
    Trono, D
    [J]. NATURE, 2003, 424 (6944) : 99 - 103
  • [7] Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
    Mariani, R
    Chen, D
    Schröfelbauer, B
    Navarro, F
    König, R
    Bollman, B
    Münk, C
    Nymark-McMahon, H
    Landau, NR
    [J]. CELL, 2003, 114 (01) : 21 - 31
  • [8] Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin
    Milazzo, L
    Biasin, M
    Gatti, N
    Piacentini, L
    Niero, F
    Poma, BZ
    Galli, M
    Moroni, M
    Clerici, M
    Riva, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) : 399 - 402
  • [9] Global burden of the HIV pandemic
    Quinn, TC
    [J]. LANCET, 1996, 348 (9020) : 99 - 106
  • [10] IMMUNE-RESPONSES IN HIV-EXPOSED SERONEGATIVES - HAVE THEY REPELLED THE VIRUS
    ROWLANDJONES, SL
    MCMICHAEL, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) : 448 - 455